과제정보
연구 과제 주관 기관 : National Natural Science Foundation of China, Nanjing Medical University
참고문헌
- Adarkwah CC, Gandjour A, Akkerman M, Evers SM. Cost-effectiveness of angiotensin-converting enzyme inhibitors for the prevention of diabetic nephropathy in the Netherlands: a Markov model. PLoS One 2011;6:e26139. https://doi.org/10.1371/journal.pone.0026139
- Foley RN, Collins AJ. The growing economic burden of diabetic kidney disease. Curr Diab Rep 2009;9:460-465. https://doi.org/10.1007/s11892-009-0075-9
- Tzamaloukas AH, Murata GH. Prevention of nephropathy in patients with type 2 diabetes mellitus. Int Urol Nephrol 2005;37:655-663. https://doi.org/10.1007/s11255-005-2394-3
- Conserva F, Pontrelli P, Accetturo M, Gesualdo L. The pathogenesis of diabetic nephropathy: focus on microRNAs and proteomics. J Nephrol 2013;26:811-20. https://doi.org/10.5301/jn.5000262
- Bhatt AP, Gupta A, Vibha D, Sharma A, Mahajan S. Florid diabetic complications in impaired glucose tolerance. Saudi J Kidney Dis Transpl 2013;24:86-88. https://doi.org/10.4103/1319-2442.106251
- Najafi M, Alipoor B, Shabani M, Amirfarhangi A, Ghasemi H. Association between rs4673 (C/T) and rs13306294 (A/G) haplotypes of NAD(P)H oxidase p22phox gene and severity of stenosis in coronary arteries. Gene 2012;499:213-217. https://doi.org/10.1016/j.gene.2012.02.032
- Perianayagam MC, Liangos O, Kolyada AY, et al. NADPH oxidase p22phox and catalase gene variants are associated with biomarkers of oxidative stress and adverse outcomes in acute renal failure. J Am Soc Nephrol 2007;18:255-263. https://doi.org/10.1681/ASN.2006070806
- Hodgkinson AD, Millward BA, Demaine AG. Association of the p22phox component of NAD(P)H oxidase with susceptibility to diabetic nephropathy in patients with type 1 diabetes. Diabetes Care 2003;26:3111-5. https://doi.org/10.2337/diacare.26.11.3111
- Liu LY, Zou DJ, Zhang J. Association between NADPH oxidase subunit p22phox gene polymorphism and type 2 diabetic nephropathy patients in Shanghai. Chin J Nephrol 2006;22:84-87.
- Yang ST, Liu H, Wang YM, Song DP. The polymorphism of C242T of p22phox gene related to diabetic nephropathy. J Kunming Med Univ 2006;27:111-115.
- Lim SC, Goh SK, Lai YR, et al. Relationship between common functional polymorphisms of the p22phox gene (-930A > G and +242C > T) and nephropathy as a result of type 2 diabetes in a Chinese population. Diabet Med 2006;23:1037-1041. https://doi.org/10.1111/j.1464-5491.2006.01916.x
- Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097. https://doi.org/10.1371/journal.pmed.1000097
- Cochran WG. The effectiveness of adjustment by subclassification in removing bias in observational studies. Biometrics 1968;24:295-313. https://doi.org/10.2307/2528036
- DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188. https://doi.org/10.1016/0197-2456(86)90046-2
- Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-748.
- Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-634. https://doi.org/10.1136/bmj.315.7109.629
- Santos KG, Canani LH, Gross JL, Tschiedel B, Souto KE, Roisenberg I. Relationship of p22phox C242T polymorphism with nephropathy in type 2 diabetic patients. J Nephrol 2005;18:733-738.
- Hong YR, Han L, Huang J, Kleinberg ME. Elimination of false negative results in the two-hybrid system in the phagocyte NADPH oxidase. Kaohsiung J Med Sci 1996;12:301-305.
- Inoue N, Kawashima S, Kanazawa K, Yamada S, Akita H, Yokoyama M. Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. Circulation 1998;97:135-137. https://doi.org/10.1161/01.CIR.97.2.135
- Guzik TJ, West NE, Black E, et al. Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis. Circulation 2000;102:1744-1747. https://doi.org/10.1161/01.CIR.102.15.1744
-
Liu CC, Karimi Galougahi K, Weisbrod RM, et al. Oxidative inhibition of the vascular Na+-K+ pump via NADPH oxidase-dependent
${\beta}1$ -subunit glutathionylation: implications for angiotensin II-induced vascular dysfunction. Free Radic Biol Med 2013;65:563-572. https://doi.org/10.1016/j.freeradbiomed.2013.06.040 - Cahilly C, Ballantyne CM, Lim DS, Gotto A, Marian AJ. A variant of p22(phox), involved in generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosis. Circ Res 2000;86:391-395. https://doi.org/10.1161/01.RES.86.4.391
- Ito D, Murata M, Watanabe K, et al. C242T polymorphism of NADPH oxidase p22 PHOX gene and ischemic cerebrovascular disease in the Japanese population. Stroke 2000;31:936-939. https://doi.org/10.1161/01.STR.31.4.936
- Ji Z, Lu BX, Wang XY, Pan SY. C242T p22phox gene polymorphism in the population of Han nationality in Guangdong province. Di Yi Jun Yi Da Xue Xue Bao 2003;23:387-388, 390.
- Li A, Prasad A, Mincemoyer R, et al. Relationship of the C242T p22phox gene polymorphism to angiographic coronary artery disease and endothelial function. Am J Med Genet 1999;86:57-61. https://doi.org/10.1002/(SICI)1096-8628(19990903)86:1<57::AID-AJMG11>3.0.CO;2-R
- Saha N, Sanghera DK, Kamboh MI. The p22 phox polymorphism C242T is not associated with CHD risk in Asian Indians and Chinese. Eur J Clin Invest 1999;29:999-1002. https://doi.org/10.1046/j.1365-2362.1999.00575.x
피인용 문헌
- Association of Polymorphisms in CYBA , SOD1 , and CAT Genes with Type 1 Diabetes and Diabetic Peripheral Neuropathy in Children and Adolescents vol.22, pp.7, 2018, https://doi.org/10.1089/gtmb.2018.0018
- Anti‐Inflammatory and Antioxidative Properties of Isoflavones Provide Renal Protective Effects Distinct from Those of Dietary Soy Proteins against Diabetic Nephropathy vol.64, pp.10, 2017, https://doi.org/10.1002/mnfr.202000015